1. |
Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer, 2021, 127(16): 3029-3030.
|
2. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
3. |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?. Cancer Commun (Lond), 2019, 39(1): 22. doi: 10.1186/s40880-019-0368-6.
|
4. |
Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data. Lancet Public Health, 2023, 8(12): e943-e955. doi: 10.1016/S2468-2667(23)00211-6.
|
5. |
Wang Y, Li X, Zhou M, et al. Under-5 mortality in 2 851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China. Lancet, 2016, 387(10015): 273-283.
|
6. |
Wang W, Yin P, Liu YN, et al. Mortality and years of life lost of colorectal cancer in China, 2005–2020: findings from the national mortality surveillance system. Chin Med J (Engl), 2021, 134(16): 1933-1940.
|
7. |
郑荣寿, 陈茹 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析. 中华肿瘤杂志, 2024, 46(3): 221-231.
|
8. |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl), 2021, 134(7): 783-791.
|
9. |
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond), 2021, 41(10): 1037-1048.
|
10. |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6(5): e555-e567. doi: 10.1016/S2214-109X(18)30127-X.
|
11. |
Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin, 2022, 72(5): 409-436.
|
12. |
Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med, 2020, 41(1): 1-24.
|
13. |
Li X, Galea G. Healthy China 2030: an opportunity for tobacco control. Lancet, 2019, 394(10204): 1123-1125.
|
14. |
Lancaster HL, Heuvelmans MA, Oudkerk M. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research. J Intern Med, 2022, 292(1): 68-80.
|
15. |
范亚光, 周清华, 乔友林, 等. 中国肺癌低剂量CT筛查指南(2023年版). 中国肺癌杂志, 2023, 26(1): 1-9.
|
16. |
Zhu Y, Shao X, Wang X, et al. Sex disparities in cancer. Cancer Lett, 2019, 466: 35-38.
|
17. |
Kwak K, Kang D, Paek D. Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis. Occup Environ Med, 2022, 79(3): 207-214.
|
18. |
Yang T, Qiao Y, Xiang S, et al. Work stress and the risk of cancer: A meta-analysis of observational studies. Int J Cancer, 2019, 144(10): 2390-2400.
|
19. |
Marino P, Mininni M, Deiana G, et al. Healthy lifestyle and cancer risk: modifiable risk factors to prevent cancer. Nutrients, 2024, 16(6): 800. doi: 10.3390/nu16060800.
|
20. |
Zare Sakhvidi MJ, Lequy E, Goldberg M, et al. Air pollution exposure and bladder, kidney and urinary tract cancer risk: A systematic review. Environ Pollut, 2020, 267: 115328. doi: 10.1016/j.envpol.2020.115328.
|
21. |
Cazzolla Gatti R, Di Paola A, Monaco A, et al. The spatial association between environmental pollution and long-term cancer mortality in Italy. Sci Total Environ, 2023, 855: 158439. doi: 10.1016/j.scitotenv.2022.158439.
|